Heart to Heart: Cardiovascular Risk in RA Tune in to hear experts discuss cardiovascular risk assessment, patient education, and the importance of disease control in the latest therapeutic update sponsored by AbbVie US Medical Affairs. https://t.co/Tz8VBiXhwt https://t.co/EQ0dRmM27r

When Hannah Glick receives her M.D. this week, she will join her mother, Dr. Rachel Glick, and grandmother, Dr. Marilyn Heins, as the only family in the U.S. with three generations of women doctors that are living, according to @AAMCtoday. https://t.co/AzRw2I4CU8 #GoBlueMed https://t.co/0tgMwVLwxF

View an interactive disease modification patient journey from the #LupusEducatorsNetwork and learn about the importance of helping to prevent renal damage in your patients with #LupusNephritis. #SponsoredbyGSKUSMA https://t.co/XKG25eVSfa https://t.co/Jbo2iR6OuJ

2010 Colchicine Price Hikes Adversely Affected Gout Care Research shows that the large increase in colchicine cost in 2010 was associated with an immediate decrease in colchicine prescription use,. https://t.co/WS721SlM6p https://t.co/BBdqDVGolq

Orphan drugs target rare dz <200k. New drugs (2008-2016) compared 5 yr sales 86 orphan Rx to 232 non-orphan = similar sales- Orphan ($719 mill) vs nonorphan ($812 mill). But orphan Rx lower volume offset by higher prices (7X higher) than nonorphan drugs https://t.co/I8kb4A0eyG https://t.co/gEQpssRVkg

May 16th--Tuesday Night Rheumatology: POD 3: Vasculitis: Evolution and Advances This webinar will feature highlights from these lectures followed by live audience Q & A: -New Therapies for PMR & GCA -Assessment of GCA and PMR -GPA Treatment Choices https://t.co/fphj3seU3K https://t.co/GSL41UZZ2Y

Pregnancy in PsA RheumNow Live 2023: Christina Chambers, PhD, MPH, University of California, San Diego School of Medicine https://t.co/ImgAwCvawE https://t.co/9GCZ1tBmkV

Study of 6039 NHL hockey players showed mortality rates were similar between fighters & controls (3.9% v4.2%) & Penalized vs not (7.1.% v 5.5%). Yet controls lived (~56yrs) avg of 10 yrs longer than fighters/penalized (~46yrs) w/ more suicide & overdose https://t.co/EKOeEKSejN https://t.co/7Axpz0QibY

JAK inhibitors in Psoriasis and PsA RheumNow Live 2023: Eric Ruderman, MD, Northwestern University, Feinberg School of Medicine https://t.co/OV4rRR6eCh https://t.co/uY9MnwGveV

B-Cell Stimulating Factors Tied to Lymphoma in Sjogren's Genetic blood tests indicated that BTK and a cytokine called APRIL were overexpressed in patients with primary Sjögren's syndrome who subsequently developed lymphoma, French researchers reported. https://t.co/SPmdBJ8IFh https://t.co/ad2j6XaSkK

Did you miss Tuesday Night Rheumatology this week? This webinar features highlights from: Preclinical RA – To Treat or Not To Treat Year of the JAKi Fibroblast/Stromal Cells https://t.co/yVQLtG6fEe https://t.co/WMXcKdqwdP

Another NHANES survey of US adults shows increased prevalence of RA for those exposed to high levels of polycyclic aromatic hydrocarbons (PAH)(OR: 1.8; p=0.02). 90% of the smoking effect on RA risk is mediated by PAH https://t.co/N93MbKspRM https://t.co/uqH75vOZrA